SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Formerly About Advanced Micro Devices
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: i-node who wrote (889560)9/22/2015 6:50:00 PM
From: combjelly  Read Replies (1) of 1576221
 
*HE* hasn't made it impossible. FDA has.

You have a habit of speaking authoritatively on something you know nothing about. If you had bothered to read that excerpt I provided, or clicked the link, you would know that he is selling the drug through closed distribution. Because of that, he can control the amounts of the drug and there isn't enough for a potential competitor to do a clinical.

I do not believe that every generic ought to have to go through a high-dollar, bureaucratic approval process.

It doesn't. If you had bothered to read the article, you would know that they only have to prove it is as effective as the original. Which makes sense, they already know if it is effective or not. And whether or not it is safe.

As I said before, the present requirements for clinical trials takes too long and costs too much money. But that is a different issue than what we have here.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News